SFS
BEAM icon

Sowell Financial Services’s Beam Therapeutics BEAM Stock Holding History

Sowell Financial Services’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-91
Closed -$6K – 748
2021
Q1 		$6K Buy
+91
New +$8.66K ﹤0.01% 2510

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sowell Financial Services's BEAM Position: Q2 2021 in Review

Sowell Financial Services sold out of Beam Therapeutics (BEAM) in Q2 2021, closing a stake of 91 shares — an estimated $6K sold.

Sowell Financial Services first reported a position in BEAM in Q1 2021 and held it in 1 quarter. The position peaked at $6K in Q1 2021. 231 funds tracked by Wall St. Rank hold BEAM as of Q2 2021.

  • Sowell Financial Services reported no remaining Beam Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 91 Beam Therapeutics shares in Q2 2021, an estimated $6K.
  • Sowell Financial Services first reported a position in Beam Therapeutics in Q1 2021 and held it in 1 quarter.
  • Sowell Financial Services's Beam Therapeutics position peaked at $6K in Q1 2021.
  • 231 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.